Search This Blog

Wednesday, May 1, 2019

Syros Pharmaceuticals plans to complete studies of SY-5609 in 2019

Syros plans to complete investigational new drug-enabling studies of SY-5609 in 2019 to support the initiation of a Phase 1 oncology trial in early 2020.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)